PAI
Palo Alto Investors Portfolio holdings
AUM
$470M
This Quarter Return
+15.32%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$1.07B
AUM Growth
+$1.07B
(+12%)
Cap. Flow
-$38.4M
Cap. Flow
% of AUM
-3.58%
Top 10 Holdings %
Top 10 Hldgs %
72.05%
Holding
37
New
3
Increased
23
Reduced
6
Closed
3
Top Buys
| 1 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
$23.5M |
| 2 |
CBST
CUBIST PHARMACEUTICALS INC
CBST
|
$22.1M |
| 3 |
KYTH
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
|
$21.7M |
| 4 |
QCOR
QUESTCOR PHARMA INC
QCOR
|
$16.8M |
| 5 |
NPSP
NPS PHARMACEUTICALS INC
NPSP
|
$13.3M |
Top Sells
| 1 |
VPHM
VIROPHARMA INC
VPHM
|
$140M |
| 2 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
$42.8M |
| 3 |
SVNT
SAVIENT PHARMACEUTICALS INC
SVNT
|
$5.47M |
| 4 |
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
|
$3.81M |
| 5 |
Rigel Pharmaceuticals
RIGL
|
$3.09M |
Sector Composition
| 1 | Healthcare | 44.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CYBX
1
DELISTED
CYBERONICS INC
CYBX
| $128M | 11.91% | 1,951,581 +32,063 | +2% | +$2.1M |
|
2
United Therapeutics
UTHR
$13.8B
| $124M | 11.56% | 1,095,428 +31,986 | +3% | +$3.62M |
|
|
AUXL
3
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $101M | 9.44% | 4,883,879 +320,359 | +7% | +$6.64M |
|
|
CBST
4
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $92M | 8.58% | 1,336,136 +321,525 | +32% | +$22.1M |
|
|
ABMD
5
DELISTED
Abiomed Inc
ABMD
| $71.9M | 6.7% | 2,687,347 +33,000 | +1% | +$882K |
|
|
ITMN
6
DELISTED
INTERMUNE INC
ITMN
| $56.3M | 5.25% | 3,819,606 +223,850 | +6% | +$3.3M |
|
|
QCOR
7
DELISTED
QUESTCOR PHARMA INC
QCOR
| $52.5M | 4.9% | 963,995 +307,998 | +47% | +$16.8M |
|
8
BioMarin Pharmaceuticals
BMRN
$11.2B
| $52.1M | 4.86% | 741,087 +176,800 | +31% | +$12.4M |
|
9
STAAR Surgical
STAA
$1.36B
| $52M | 4.85% | 3,214,253 +2,935 | +0.1% | +$47.5K |
|
|
AMAG
10
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $42.8M | 3.99% | 1,761,332 +45,955 | +3% | +$1.12M |
|
11
Vanda Pharmaceuticals
VNDA
$279M
| $40.2M | 3.75% | 3,238,624 +330,310 | +11% | +$4.1M |
|
|
KYTH
12
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $33.6M | 3.14% | 900,559 +581,446 | +182% | +$21.7M |
|
|
ANAC
13
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $26.9M | 2.51% | 1,603,278 +3,100 | +0.2% | +$52K |
|
|
ARIA
14
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $23.5M | 2.19% | +3,441,324 | New | +$23.5M |
|
|
SQNM
15
DELISTED
SEQUENOM INC NEW
SQNM
| $22M | 2.05% | 9,394,627 +1,192,373 | +15% | +$2.79M |
|
|
MNTA
16
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $20.5M | 1.91% | 1,157,276 +20,600 | +2% | +$364K |
|
|
ALIM
17
DELISTED
Alimera Sciences, Inc.
ALIM
| $17.1M | 1.59% | 3,634,984 | – | – |
|
|
18
Rigel Pharmaceuticals
RIGL
$697M
| $14.9M | 1.39% | 5,217,001 -1,082,663 | -17% | -$3.09M |
|
|
VPHM
19
DELISTED
VIROPHARMA INC
VPHM
| $14.5M | 1.35% | 290,916 -2,802,375 | -91% | -$140M |
|
20
Prothena Corp
PRTA
$441M
| $14.3M | 1.33% | 537,418 +448,918 | +507% | +$11.9M |
|
|
NPSP
21
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $13.3M | 1.24% | +439,100 | New | +$13.3M |
|
|
QLTI
22
DELISTED
QLT Inc
QLTI
| $11.4M | 1.07% | 2,053,311 +900 | +0% | +$5.01K |
|
|
CLVS
23
DELISTED
Clovis Oncology, Inc.
CLVS
| $11.3M | 1.05% | +186,900 | New | +$11.3M |
|
24
Amicus Therapeutics
FOLD
$2.34B
| $9.42M | 0.88% | 4,008,576 -613,654 | -13% | -$1.44M |
|
25
Exact Sciences
EXAS
$8.98B
| $9.23M | 0.86% | 785,776 +5,900 | +0.8% | +$69.3K |
|